抗癌新药NSC319726对卵巢癌基因表达影响的研究

doi:10.11904/j.issn.1002-3070.2016.04.009

实用肿瘤学杂志 ›› 2016, Vol. 30 ›› Issue (4): 332-338.doi: 10.11904/j.issn.1002-3070.2016.04.009

抗癌新药NSC319726对卵巢癌基因表达影响的研究

邓燕红¹,乐秀²,高文超³

1.广州医科大学附属第三医院(广州 510150);
2.中山大学药学院;
3.中山大学附属第三医院

收稿日期:2016-05-02 出版日期:2016-08-10 发布日期:2016-08-19
通讯作者: 高文超,E-mail:gwc19880401@163.com
作者简介:邓燕红,女,(1986-),硕士,药师,从事抗肿瘤药物的研究

The effects of anti-cancer drug NSC319726 on the gene expression of ovarian cancer

DENG Yanhong¹,LE Xiu²,GAO Wenchao³

1.The Third Affiliated Hospital of Guangzhou Medical University,Guangzhou 510150,China;
2.The School of Pharmaceutical Science,Sun Yat-sen University;
3 The Third Affiliated Hospital of Sun Yat-Sen University

Received:2016-05-02 Online:2016-08-10 Published:2016-08-19

摘要/Abstract

摘要： 目的研究抗癌新药NSC319726对卵巢癌基因表达的影响。方法下载GEO数据库,研究NSC319726对卵巢癌细胞系TOV112D影响的数据,进行生物信息学分析。结果 NSC319726上调卵巢癌细胞246个基因、下调198个基因;上调基因包括MMP3与CXCR4等,下调基因包括PBX1等。GO分析中,我们发现6个GO条目与物质代谢有关。Pathway分析发现,NSC319726可以影响生物钟及MMP信号通路相关基因。结论抗癌新药NSC319726可影响卵巢癌细胞系中多个功能基因的表达,因此它可能是前体B细胞急性淋巴细胞白血病潜在的治疗药物。但需要注意的是,NSC319726也可能对肿瘤转移、人体睡眠产生不利影响,故临床运用前有待更多研究。

关键词: NSC319726, 卵巢癌, 生物信息学分析, GO分析, MMP信号通路

Abstract: Objective To study the effects of anti-cancer drug NSC319726 on the gene expression of ovarian cancer.Methods The data that NSC319726 acted on the ovarian cancer cell lines TOV112D was downloaded from the GEO database and then the bioinformatical analysis was conducted.Results NSC319726 increased 246 genes including MMP3,CXCR4 et al and decreased 198 genes such as PBX1 in ovarian cancer cell lines.GO analysis indicated that six GO items were related to metabolism.Pathway analysis revealed that NSC319726 could affect the circadian clock and MMP signaling pathway.Conclusion NSC319726 could affect the expression of multiple functional genes in ovarian cancer cell lines and might be a potential drug targeting to the precursor-B cell acute lymphoblastic leukemia.Meanwhile,it should be noted that NSC319726 may have effects on the tumor metastasis and human sleep.Therefore,further research needs to be conducted before the clinical use.

Key words: NSC319726, Ovarian cancer, Bioinformatic analysis, GO analysis, MMP signaling pathway

中图分类号:

R737.31

邓燕红,乐秀,高文超. 抗癌新药NSC319726对卵巢癌基因表达影响的研究[J]. 实用肿瘤学杂志, 2016, 30(4): 332-338.

DENG Yanhong ,LE Xiu ,GAO Wenchao. The effects of anti-cancer drug NSC319726 on the gene expression of ovarian cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(4): 332-338.

参考文献

1 闫毓秀,张淑萍,滑静.p53基因研究进展[J].北京农学院学报,2009,24(2):74-77.
2 姬明丽,千智斌,徐自超.p53蛋白与非小细胞肺癌多药耐药性的关系[J].新乡医学院学报,2008,25(1):13-15.
3 闵婕,李刚,宋扬,等.原发性肝细胞癌p53蛋白和多药耐药相关蛋白的表达及意义[J].现代肿瘤医学,2005,13(4):444-446.
4 何春梅,刘斌,王柯敏,等.p53及p21~(waf1)蛋白表达与人舌癌细胞多药耐药性的关系[J].中国医师杂志,2006,8(9):1189-1192.
5 Yu X,Vazquez A,Levine AJ,et al.Allele-specific p53 mutant reactivation[J].Cancer Cell,2012,21(5):614-625.
6 成秀梅.肿瘤抑制基因p53的研究进展[J].现代诊断与治疗,2008,19(3):158-160.
7 甄一松,张伟丽,吴青,等.R/Bioconductor在Affymetrix表达芯片中的应用[J].生物信息学,2011,9(2):138-141.
8 王胜军,郭云波,杨俊,等.基于Bioconductor的微阵列数据处理平台[J].北京生物医学工程,2010,29(5):531-533.
9 Jones L,Goldstein DR,Hughes G,et al.Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data[J].BMC Bioinformatics,2006,7(1):1-18.
10 Hu Z.Using visANT to analyze networks[J].Curr Protoc Bioinformatics,2014,8(3):1-39.
11 周婷婷,容健锋,陈振冲,等.MetaGen:从KEGG建模代谢网络的新工具[J].生物化学与生物物理进展,2010,1(6):63-68.
12 Hofmann UB,Houben R,Brocker EB,et al.Role of matrix metalloproteinases in melanoma cell invasion[J].Biochimie,2005,87(3):307-314.
13 苏丽萍,张进平,徐焕宾,等.CXCR4在肺癌转移中的作用及其机制研究[J].中华医学杂志,2005,85(17):1190-1194.
14 Mendes O,Kim HT,Stoica G.Expression of MMP2,MMP9 and MMP3 in breast cancer brain metastasis in a rat model[J].Clin Exp Metastasis,2005,22(3):237-246.
15 Ren Z,Liang S,Yang J,et al.Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma[J].Tumour Biol,2016,37(4):5089-5096.
16 Woodcroft MW,Nanan K,Thompson P,et al.Retrovirus-mediated expression of E2A-PBX1 blocks lymphoid fate but permitsretention of myeloid potential in early hematopoietic progenitors[J].PLoS One,2015,10(6):e130495.
17 Fong MY,Zhou W,Liu L,et al.Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis[J].Nat Cell Biol,2015,17(2):183-194.
18 谢朝晖,佘秋生,邵宝平,等.哺乳动物生物钟昼夜节律同步机制的研究进展[J].西北农林科技大学学报(自然科学版),2005,33(9):45-52.
19 Cao R,Ji H,Feng N,et al.Collaborative interplay between FGF-2 and VEGF-C promotes lymph angiogenesis and metastasis[J].Proc Natl Acad Sci U S A,2012,109(39):15894-15899.
20 Kodama M,Kitadai Y,Sumida T,et al.Expression of platelet-derived growth factor(PDGF)-B and PDGF-receptor beta is associated with lymphatic metastasis in human gastric carcinoma[J].Cancer Sci,2010,101(9):1984-1989.
21 Fan Q,He M,Deng X,et al.Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma[J].Cell Biochem Funct,2013,31(4):319-324.

[1]	吕博文, 钱钧, 王杰, 钱景荣, 卢莹莹, 苏丽菊, 杨桐树, 李文辉. miR-455-5p在上皮性卵巢癌中表达研究及其靶基因功能分析[J]. 实用肿瘤学杂志, 2019, 33(2): 115-121.
[2]	宋玲, 付琼. 紫云英苷通过抑制HIF-1α诱导的糖酵解途径发挥抗卵巢肿细胞作用的研究[J]. 实用肿瘤学杂志, 2018, 32(6): 503-509.
[3]	姜亮亮综述, 王晶审校. 上皮性卵巢癌远处转移的诊治进展[J]. 实用肿瘤学杂志, 2018, 32(5): 480-482.
[4]	梁冠盈, 迟秋君, 李晓梅. 伏立诺他对卵巢癌SKOV3细胞增殖和凋亡的影响及机制研究[J]. 实用肿瘤学杂志, 2018, 32(4): 298-302.
[5]	李文辉, 吕博文, 钱钧, 苏丽菊, 杨桐树, 钱景荣, 王杰. MicroRNA-150对上皮性卵巢癌细胞增殖、凋亡和侵袭转移能力的影响[J]. 实用肿瘤学杂志, 2018, 32(3): 208-213.
[6]	毕琦玲, 周立红, 韩毅敏. HOX基因与妇科肿瘤的研究进展[J]. 实用肿瘤学杂志, 2018, 32(2): 140-143.
[7]	陈丹, 李加桩, 隋红. 阿帕替尼多重癌1例附文献回顾[J]. 实用肿瘤学杂志, 2017, 31(5): 441-443.
[8]	于歌, 孙佳宁, 冯晓玲. 上皮性卵巢肿瘤组织中PSMD10、Ki67的表达及其临床病理意义[J]. 实用肿瘤学杂志, 2017, 31(2): 112-116.
[9]	柴静波, 李萍, 裴志萍. 番茄红素对荷卵巢癌大鼠免疫功能的影响及其机制研究[J]. 实用肿瘤学杂志, 2017, 31(1): 13-17.
[10]	余东阳,刘梓良,韩丽蓉. 58例晚期卵巢癌患者发生腹腔内转移后的临床特征、疗效及预后影响因素分析[J]. 实用肿瘤学杂志, 2016, 30(4): 321-326.
[11]	郭爽, 刘端阳, 李静, 李佳德, 金晓明. 癌性腹水对卵巢癌细胞增殖及迁移的影响[J]. 实用肿瘤学杂志, 2016, 30(1): 36-40.
[12]	于歌,杨先,刘晓东,邵华,赵玉兰,王晶. HIF-1α促进卵巢癌贝伐单抗耐药的研究[J]. 实用肿瘤学杂志, 2015, 29(4): 294-298.
[13]	靳红, 谢凯, 张美丽, 孙晶, 董猷元. cIAP1基因的RNA干扰载体的构建及其对卵巢癌细胞的生物学影响[J]. 实用肿瘤学杂志, 2015, 29(1): 17-21.
[14]	万静华, 傅振坤. 抑制性协同刺激分子B7-H4在女性常见恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2015, 29(1): 53-56.
[15]	宋雨霖综述, 王晶审校. 卵巢癌术前新辅助化疗筛选与评估的展望[J]. 实用肿瘤学杂志, 2014, 28(6): 553-556.

抗癌新药NSC319726对卵巢癌基因表达影响的研究

The effects of anti-cancer drug NSC319726 on the gene expression of ovarian cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价